MEMORANDUM OF UNDERSTANDING KANGER INTERNATIONAL BERHAD ("KANGER" OR "THE GROUP") UPDATE ON MEMORANDUM OF UNDERSTANDING ("MOU") BETWEEN KANGER AND ZUELLIG PHARMA SDN. BHD. ("ZP")

KANGER INTERNATIONAL BERHAD

Type Announcement
Subject MEMORANDUM OF UNDERSTANDING
Description 
KANGER INTERNATIONAL BERHAD ("KANGER" OR "THE GROUP")
UPDATE ON MEMORANDUM OF UNDERSTANDING ("MOU") BETWEEN KANGER AND ZUELLIG PHARMA SDN. BHD. ("ZP")

Reference is made to the announcement dated 26 October 2020 pertaining to the MOU made between the Kanger and ZP for the purpose of collaboration on the distribution of Covid-19 vaccines in Malaysia. 

The Board of Directors of the Company wishes to announce that the Company is being allocated 10,000 doses of vaccines for trial purposes and will be getting approval from relevant authorities.

The first batch of vaccines is expected to arrive in May 2021.

This announcement is dated 9 March 2021.



Announcement Info

Company Name KANGER INTERNATIONAL BERHAD
Stock Name KANGER
Date Announced 09 Mar 2021
Category General Announcement for PLC
Reference Number GA1-08032021-00059